Clinical benefits of a multivariate prediction model for bladder cancer: a decision analytic approach.
about
A systematic review of the tools available for predicting survival and managing patients with urothelial carcinomas of the bladder and of the upper tract in a curative setting.Who should be included in a clinical trial of screening for bladder cancer?: a decision analysis of data from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.Predictive and prognostic models in radical prostatectomy candidates: a critical analysis of the literature.Prediction models in cancer care.Statistical consideration for clinical biomarker research in bladder cancer.Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling.Predictive tools for clinical decision-making and counseling of patients with upper tract urothelial carcinoma.Contemporary gender-specific outcomes in Germany after radical cystectomy for bladder cancer.Targeting chemotherapy to advanced bladder cancer patients most likely to benefit.Do we have biomarkers to predict response to neoadjuvant and adjuvant chemotherapy and immunotherapy in bladder cancer?Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy.
P2860
Q33439263-4E49EB13-1BC8-403D-A422-C4EB37BE34A1Q33677904-F5D761EF-74C9-4D3F-A63E-BA71DB8FA17DQ33993472-A35F48D4-9664-42E7-9B3D-511F86CDD6BDQ35292878-E5171154-3048-4516-A027-6B239F34630DQ36124883-C1D6F2E7-D97C-4A94-AF18-DD47A9F9042AQ36419132-2F90FFFD-34FF-4D2D-BEE6-D04592A24B0BQ38044252-DBF59108-6B42-413F-B183-3F4167222FB8Q38206405-D528C5A1-5B90-4CA3-94C4-20DB2D6EF29EQ39901909-17D8D9D9-56BA-4D1E-9259-8E3F001731E6Q49246529-0AE468F7-A99E-4C02-BCC9-D36BAC57CE12Q50493416-56DBB39C-676A-497D-B6B5-E5E5A2B0553F
P2860
Clinical benefits of a multivariate prediction model for bladder cancer: a decision analytic approach.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical benefits of a multiva ...... a decision analytic approach.
@en
Clinical benefits of a multiva ...... a decision analytic approach.
@nl
type
label
Clinical benefits of a multiva ...... a decision analytic approach.
@en
Clinical benefits of a multiva ...... a decision analytic approach.
@nl
prefLabel
Clinical benefits of a multiva ...... a decision analytic approach.
@en
Clinical benefits of a multiva ...... a decision analytic approach.
@nl
P2093
P2860
P356
P1433
P1476
Clinical benefits of a multiva ...... a decision analytic approach.
@en
P2093
Angel M Cronin
Guido Dalbagni
International Bladder Cancer Nomogram Consortium
Matthew I Milowsky
Michael W Kattan
Mithat Gonen
Peter T Scardino
P2860
P304
P356
10.1002/CNCR.24615
P407
P577
2009-12-01T00:00:00Z